当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析

甘李药业

(603087)

  

流通市值:249.60亿  总市值:270.84亿
流通股本:5.54亿   总股本:6.01亿

甘李药业(603087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.07亿元,每股收益0.85元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1120686.43万元,未分配利润695165.66万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1222162.07万元,负债101475.63万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,245,006,087.121,314,892,845.25560,334,209.72,608,036,951.05
营业总成本1,921,772,067.241,182,053,775.74541,954,966.182,306,681,448.38
营业利润562,258,052.99339,349,020.28113,115,835.01315,285,985.89
利润总额563,604,698.92340,852,532.63113,560,343.98306,141,077.24
净利润507,265,199.52298,904,048.996,004,233.73340,231,490.19
其他综合收益-865,256.02-138,136.72-110,985.06375,299.98
综合收益总额506,399,943.5298,765,912.1895,893,248.67340,606,790.17
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计6,488,421,495.556,330,733,352.246,215,027,747.416,175,749,710.54
非流动资产合计5,733,199,169.995,621,824,055.465,504,926,666.175,539,273,761.26
资产总计12,221,620,665.5411,952,557,407.711,719,954,413.5811,715,023,471.8
流动负债合计806,674,618.97763,712,151.04682,351,020.81773,449,046.88
非流动负债合计208,081,711.71211,756,005.29195,012,503.62199,067,997.28
负债合计1,014,756,330.68975,468,156.33877,363,524.43972,517,044.16
归属于母公司股东权益合计11,206,864,334.8610,977,088,892.8210,842,590,528.910,742,506,022.92
股东权益合计11,206,864,334.8610,977,089,251.3710,842,590,889.1510,742,506,427.64
负债和股东权益合计12,221,620,665.5411,952,557,407.711,719,954,413.5811,715,023,471.8
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,482,539,982.351,380,224,740.95688,698,883.712,575,236,902.78
经营活动现金流出小计2,017,199,688.51,313,989,136.4607,410,528.982,465,784,818.05
经营活动产生的现金流量净额465,340,293.8566,235,604.5581,288,354.73109,452,084.73
投资活动现金流入小计7,094,140,190.144,654,889,630.382,330,957,463.527,577,646,457.69
投资活动现金流出小计7,574,018,744.44,853,118,291.862,359,857,245.638,555,043,985.73
投资活动产生的现金流量净额-479,878,554.26-198,228,661.48-28,899,782.11-977,397,528.04
筹资活动现金流入小计139,321,600139,321,600-759,727,968.07
筹资活动现金流出小计137,407,531.31102,760,854.76951,940.655,029,339.4
筹资活动产生的现金流量净额1,914,068.6936,560,745.24-951,940.65754,698,628.67
汇率变动对现金及现金等价物的影响-1,572,201.8-217,668.8544,446.572,356,912.25
现金及现金等价物净增加额-14,196,393.52-95,649,980.5451,481,078.54-110,889,902.39
期末现金及现金等价物余额272,242,587.07190,789,000.05337,920,059.13286,438,980.59
TOP↑